In the George-SCLC cohort, the univariate COX model showed that high activation of the TGFB pathway was associated with an improved prognosis in SCLC patients treated with platinum-based chemotherapy (p = 0.035, Figure 3(d)). Here, TGFB1 is linked to small cell lung carcinoma.